RAPT·75382E109·UW·equity·Healthcare - Biotechnology-13D/G
RAPT (RAPT THERAPEUTICS INC) is held by 52 institutional investors as of Q4 2025. Largest holders: RTW INVESTMENTS, LP ($55.5M), VANGUARD GROUP INC ($40.2M), STATE STREET CORP ($21.7M). Net institutional sentiment: Bullish.
Showing 5 of 52 results.47 more with Pro.PROUpgrade to see all → |
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer